These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5143468)
1. [Generalized plasmacytoma with brain involvement]. Hesse P; Scholtze P; Anger G Schweiz Med Wochenschr; 1971 May; 101(21):789-92. PubMed ID: 5143468 [No Abstract] [Full Text] [Related]
2. [Plasmacytoma affecting the maxillofacial region]. Otto G; Deutschmann R Stomatol DDR; 1977 Apr; 27(4):251-6. PubMed ID: 267371 [No Abstract] [Full Text] [Related]
3. Plasma cell tumors in experimental chemotherapy: consequence of dose variation on host survival and paraprotein synthesis. Teller MN; Bowie M; Stock CC J Natl Cancer Inst; 1970 Dec; 45(6):1197-203. PubMed ID: 5488064 [No Abstract] [Full Text] [Related]
4. [Comparison of the effects of Cyclophosphamide, Cytembena and Ypenyl in the treatment of inoperable ovarian neoplasms]. Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík J Cesk Gynekol; 1971 Sep; 36(7):431-3. PubMed ID: 5110665 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy of advanced murine myeloma and subsequent resistance to tumor cell challenge. Teller MN; Bowie M; Mountain IM; Stock CC J Natl Cancer Inst; 1974 Mar; 52(3):667-71. PubMed ID: 4857022 [No Abstract] [Full Text] [Related]
6. [Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity]. Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J; Oravská D; Pokorná G; Mayer J Vnitr Lek; 1979 May; 25(5):425-35. PubMed ID: 452427 [No Abstract] [Full Text] [Related]
7. Some serum protein nitrogen mustard complexes with high chemotherapeutic selectivity. Wade R; Whisson ME; Szerkerke M Nature; 1967 Sep; 215(5107):1303-4. PubMed ID: 6052739 [No Abstract] [Full Text] [Related]
8. [Contribution to the problem of plasmacytoma without paraproteins]. Michot F Dtsch Med Wochenschr; 1968 Oct; 93(43):2072-5. PubMed ID: 5693478 [No Abstract] [Full Text] [Related]
9. [Plasmacytoma in the maxillofacial region]. Jurca M Zobozdrav Vestn; 1984; 39(4-5):99-108. PubMed ID: 6597672 [No Abstract] [Full Text] [Related]
11. Hodgkin's disease and some solid tumours. Jelliffe AM Proc R Soc Med; 1966 Dec; 59(12):1261-8. PubMed ID: 5955849 [No Abstract] [Full Text] [Related]
12. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma. Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867 [No Abstract] [Full Text] [Related]
13. [Clinical report on the cytostatic agent cytostasan]. Hesse P; Jaschke E; Anger G Dtsch Gesundheitsw; 1972 Oct; 27(43):2058-64. PubMed ID: 5087017 [No Abstract] [Full Text] [Related]
14. [Duration of disease and survival time in plasmacytoma]. Rautenstrauch H Z Gesamte Inn Med; 1970 Dec; 25(23):1071-4. PubMed ID: 5512749 [No Abstract] [Full Text] [Related]
15. [Chemotherapy of neoplasms]. Osswald H Hippokrates; 1967 Jul; 38(13):497-506. PubMed ID: 5611578 [No Abstract] [Full Text] [Related]
16. Side effects and good effects from new chemotherapeutic agents. Case 3. Bortezomib in primary refractory plasmacytoma. Chim CS; Ooi GC; Loong F; Au AW; Lie AK J Clin Oncol; 2005 Apr; 23(10):2426-8. PubMed ID: 15800336 [No Abstract] [Full Text] [Related]
18. [Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy]. Dubois-Ferrière H Schweiz Med Wochenschr; 1967 Nov; 97(44):1478-9. PubMed ID: 5631771 [No Abstract] [Full Text] [Related]
19. Transplantable mouse plasma cell tumors in experimental chemotherapy. Teller MN; Abraham D; Bowie M; Carbone PP J Natl Cancer Inst; 1969 Jul; 43(1):123-31. PubMed ID: 5816022 [No Abstract] [Full Text] [Related]
20. Single cutaneous plasmacytoma with crystalloid inclusions. Klein M; Grishman E Arch Dermatol; 1977 Jan; 113(1):64-8. PubMed ID: 831625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]